# Role of Uralyt-U in Patients With Hyperuricemia

> **NCT04352153** · NA · UNKNOWN · sponsor: **Ai Peng** · enrollment: 102 (estimated)

## Conditions studied

- Uric Acid Stones
- Hyperuricemia

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Uralyt-U

## Key facts

- **NCT ID:** NCT04352153
- **Lead sponsor:** Ai Peng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-04-01
- **Primary completion:** 2020-09-30
- **Final completion:** 2020-10-31
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2020-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04352153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04352153, "Role of Uralyt-U in Patients With Hyperuricemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04352153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*